A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis

References

• Altemus, M., Sarvaiya, N., & Epperson, C. (2014). Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol, 35(3), 320–330.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders, Five Edition. Arlington, VA: Author.
   Google Scholar
• Andreasen, N. (1983). The scale for the assessment of negative symptoms (SANS). Iowa City: University of Iowa.
   Google Scholar
• Andreasen, N. (1984). The scale for the assessment of positive symptoms (SAPS). Iowa City: University of Iowa.
   Google Scholar
• Angrist, B., & Gershon, S. (1970). The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biological Psychiatry, 2, 95–107.
   PubMedGoogle Scholar
• Arunogiri, S., Foulds, J., Mcketin, R., & Lubman, D. (2018). A systematic review of risk factors for methamphetamine-associated psychosis. Australian & New Zealand Journal of Psychiatry, 52(6), 514–529.
   PubMed Web of Science ®Google Scholar
• Bell, D. (1965). Comparison of amphetamine psychosis and schizophrenia. The British Journal of Psychiatry: The Journal of Mental Science, 111, 701–707.
   PubMed Web of Science ®Google Scholar
• Bell, D. (1973). The experimental reproduction of amphetamine psychosis. Archives of General Psychiatry, 29(1), 35–40.
   PubMed Web of Science ®Google Scholar
• Bramness, J. G., Gundersen, Ø. H., Guterstam, J., Rognli, E. B., Konstenius, M., Løberg, E.-M., … Franck, J. (2012). Amphetamine-induced psychosis: A separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry, 12, 221
   PubMed Web of Science ®Google Scholar
• Chen, C.-K., Lin, S.-K., Chen, Y.-C., Huang, M.-C., Chen, T.-T., Ree, S. C., & Wang, L.-J. (2015). Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users. Drug and Alcohol Dependence, 148, 158–164.
   PubMed Web of Science ®Google Scholar
• Chen, C.-K., Lin, S.-K., Sham, P. C., Ball, D., Loh, E.-W., Hsiao, C.-C., … Murray, R. M. (2003). Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine, 33(8), 1407–1414.
   PubMed Web of Science ®Google Scholar
• Chen, C., Lin, S., Sham, P., Ball, D., Loh, W., & Murray, R. (2005). Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 136B(1), 87–91.
   PubMed Web of Science ®Google Scholar
• Chinese Medical Association (2004). Chinese Classification and Diagnostic Criteria of Mental Disorder. 3rd ed. Jinan: Shandong Science and Technology Press.
   Google Scholar
• Cho, A., & Melega, W. (2002). Patterns of methamphetamine abuse and their consequences. Journal of Addictive Diseases, 21(1), 21–34.
   PubMed Web of Science ®Google Scholar
• Connell, P. (1958). Amphetamine psychosis. London: Oxford Press.
   Google Scholar
• Cooper, L., Peters, L., & Andrews, G. (1998). Validity of the Composite International Diagnostic Interview (CIDI) psychosis module in a psychiatric setting. Journal of Psychiatric Research, 32(6), 361–368.
   PubMed Web of Science ®Google Scholar
• Darke, S., Kaye, S., McKetin, R., & Duflou, J. (2008). Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review, 27(3), 253–262.
   PubMed Web of Science ®Google Scholar
• Ellinwood, E. (1967). Amphetamine psychosis. I. Description of the Individuals and Process. Journal of Nervous and Mental Disease, 144(4), 273–283.
   Web of Science ®Google Scholar
• Fasihpour, B., Molavi, S., & Shariat, S. (2013). Clinical features of inpatients with methamphetamine-induced psychosis. Journal of Mental Health (Abingdon, England), 22(4), 341–349.
   PubMed Web of Science ®Google Scholar
• First, M., Spitzer, R., Gibbon, M., & Williams, J. (2002). Structured Clinical Interview for DSM-IV, Research Version. New York: New York State Psychiatric Institute.
   Google Scholar
• Foussias, G., Agid, O., Fervaha, G., & Remington, G. (2014). Negative symptoms of schizophrenia: Clinical features, relevance to real world functioning and specificity versus other CNS disorders. European Neuropsychopharmacology, 24(5), 693–709.
   PubMed Web of Science ®Google Scholar
• Glasner-Edwards, S., Mooney, L., Marinelli, C., P., Hillhouse, M., Ang, A., & Rawson, R. (2014). Methamphetamine psychosis: Epidemiology and management. CNS Drugs, 28(12), 1115–1126.
   PubMed Web of Science ®Google Scholar
• Grant, K., LeVan, T., Wells, S., Li, M., Stoltenberg, S., Gendelman, H., … Bevins, R. (2012). Methamphetamine-associated psychosis. Journal of Neuroimmune Pharmacology, 7(1), 113–139.
   PubMed Web of Science ®Google Scholar
• Hartley, S., Barrowclough, C., & Haddock, G. (2013). Anxiety and depression in psychosis: A systematic review of associations with positive psychotic symptoms. Acta Psychiatrica Scandinavica, 128(5), 327–346.
   PubMed Web of Science ®Google Scholar
• Iwanami, A., Sugiyama, A., Kuroki, N., Toda, S., Kato, N., Nakatani, Y., … Kaneko, T. (1994). Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. Acta Psychiatrica Scandinavica, 89(6), 428–432.
   PubMed Web of Science ®Google Scholar
• Javadian, S., Shabani, A., & Shariat, S. (2016). Clinical course of methamphetamine-induced psychotic disorder in a 3-month follow-up. Prim Care Companion CNS Disord, 18(6). doi: 10.1016/j.jsat.2007.12.004
   PubMedGoogle Scholar
• Jonsson, L., & Sjostrom, K. (1970). A rating scale for evaluation of the clinical course and symptomatology in amphetamine psychosis. British Journal of Psychiatry, 117(541), 661–665.
   PubMed Web of Science ®Google Scholar
• Kay, S., Fiszbein, A., & Opler, L. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276.
   PubMed Web of Science ®Google Scholar
• Kittirattanapaiboon, P., Mahatnirunkul, S., Booncharoen, H., Thummawomg, P., Dumrongchai, U., & Chutha, W. (2010). Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug and Alcohol Review, 29(4), 456–461.
   PubMed Web of Science ®Google Scholar
• Koreen, A., Lieberman, J., Alvir, J., Mayerhoff, D., Loebel, A., Chakos, M., … Cooper, T. (1993). Depression in first-episode schizophrenia. American Journal of Psychiatry, 9(2-3), 240–1648.
   Google Scholar
• Leamon, M., Flower, K., Salo, R., Nordahl, T., Kranzler, H., & Galloway, G. (2010). Methamphetamine and paranoia: The methamphetamine experience questionnaire. The American Journal on Addictions, 19(2), 155–168.
   PubMed Web of Science ®Google Scholar
• Mahoney, J., Hawkins, R., De La Garza, R., Kalechstein, A., & Newton, T. (2010). Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants. Gender Medicine, 7(5), 414–421.
   PubMedGoogle Scholar
• Martin, W., Sloan, J., Sapira, J., & Jasinski, D. (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology & Therapeutics, 12(2part1), 245–258.
   PubMed Web of Science ®Google Scholar
• McKetin, R., Baker, A., Dawe, S., Voce, A., & Lubman, D. (2017). Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders. Psychiatry Research, 251, 349–354.
   PubMed Web of Science ®Google Scholar
• McKetin, R., Dawe, S., Burns, R. A., Hides, L., Kavanagh, D. J., Teesson, M., … Saunders, J. B. (2016a). The profile of psychiatric symptoms exacerbated by methamphetamine use. Drug and Alcohol Dependence, 161, 104–109.
   PubMed Web of Science ®Google Scholar
• McKetin, R., Gardner, J., Baker, A. L., Dawe, S., Ali, R., Voce, A., … Lubman, D. I. (2016b). Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users. Psychiatry Research, 238, 166–171.
   PubMed Web of Science ®Google Scholar
• McKetin, R., Lubman, D., Baker, A., Dawe, S., & Ali, R. (2013). Dose-related psychotic symptoms in chronic methamphetamine users: Evidence from a prospective longitudinal study. JAMA Psychiatry, 70(3), 319–324.
   PubMed Web of Science ®Google Scholar
• McKetin, R., Lubman, D., Najman, J., Dawe, S., Butterworth, P., & Baker, A. (2014). Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study. Addiction, 109(5), 798–806.
   PubMed Web of Science ®Google Scholar
• McKetin, R., McLaren, J., & Kelly, E. (2005). The Sydney methamphetamine market: Patterns of supply, use, personal harms and social consequences. The National Drug Law Enforcement Research Fund Monograph series (no.13). Syndey, New South Wales: National Drug and Alcohol Research Centre.
   Google Scholar
• McKetin, R., McLaren, J., Lubman, D., & Hides, L. (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101(10), 1473–1478.
   PubMed Web of Science ®Google Scholar
• McKetin, R., McLaren, J., Lubman, D., & Hides, L. (2008). Hostility among methamphetamine users experiencing psychotic symptoms. American Journal on Addictions, 17(3), 235–240.
   PubMed Web of Science ®Google Scholar
• Medhus, S., Rognli, E., Gossop, M., Holm, B., Mørland, J., & Bramness, J. (2015). Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample. The American Journal on Addictions, 24(7), 586–589.
   PubMed Web of Science ®Google Scholar
• Niemi-Pynttäri, J., Sund, R., Putkonen, H., Vorma, H., Wahlbeck, K., & Pirkola, S. (2013). Substance-induced psychoses converting into schizophrenia: A register-based study of 18,478 finnish inpatient cases. The Journal of Clinical Psychiatry, 74(01), e94–e99.
   PubMed Web of Science ®Google Scholar
• Ochoa, S., Usall, J., Cobo, J., Labad, X., & Kulkarni, J. (2012). Gender differences in schizophrenia and first-episode psychosis: A comprehensive literature review. Schizophrenia Research and Treatment, 2012, 1–198.
   Google Scholar
• Overall, J., & Gorham, J. (1962). The brief psychiatric rating scale. Psychological Reports, 10(3), 799–812.
   Web of Science ®Google Scholar
• Rosay, A., Skroban Najaka, S., & Herz, D. (2007). Differences in the validity of self-reported drug use across five factors: Gender, race, age, type of drug, and offense seriousness. Journal of Quantitative Criminology, 23(1), 41–58.
   Web of Science ®Google Scholar
• Sato, M., Chen, C., Akiyama, K., & Otsuki, S. (1983). Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biological Psychiatry, 18, 429–440.
   PubMed Web of Science ®Google Scholar
• Sheehan, D., Lecrubier, Y., Sheehan, K., Amorim, P., Janavs, J., & Weiller, E. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 22–33.
   PubMed Web of Science ®Google Scholar
• Srisurapanont, M., Arunpongpaisal, S., Wada, K., Marsden, J., Ali, R., & Kongsakon, R. (2011). Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35(4), 959–964.
   PubMed Web of Science ®Google Scholar
• Tandon, R., Nasrallah, H., & Keshavan, M. (2009). Schizophrenia, “Just the facts” 4. Clinical features and conceptualization. Schizophrenia Research, 110(1–3), 1–23.
   PubMed Web of Science ®Google Scholar
• Tomiyama, G. (1990). Chronic schizophrenia-like states in methamphetamine psychosis. Psychiatry and Clinical Neurosciences, 44(3), 531–539.
   Google Scholar
• Tsuang, M., Simpson, J., & Kronfol, Z. (1982). Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history. Archives of General Psychiatry, 39(2), 141–147.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime (2016). World drug report. New York: United Nations.
   Google Scholar
• van Os, J. (2014). The many continua of psychosis. JAMA Psychiatry, 71, 985–986.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (1992). ICD-10 Classification of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. Geneva: Author.
   Google Scholar
• Yeh, H., Lee, Y., Sun, H., & Wan, S. (2001). Six months follow-up of patients with methamphetamine psychosis. Chinese Medical Journal, 64, 388–394.
   Google Scholar